Floriva
Generic: CHOLECALCIFEROL and SODIUM FLUORIDE
- Manufacturer
- Exeltis
- NDC
- 52796-172
- RxCUI
- 1596005
- Route
- ORAL
- ICD-10 indication
- E11.9
Affordability Check
How much will you actually pay for Floriva?
In 30 seconds, see every legitimate way to afford Floriva — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About Floriva
Floriva is a prescription dietary supplement containing sodium fluoride, primarily used to prevent dental cavities in children. It is prescribed for pediatric patients residing in areas with inadequate fluoride in the drinking water to help strengthen tooth enamel and increase resistance to tooth decay.
Copay & patient assistance
Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for CHOLECALCIFEROL and SODIUM FLUORIDE.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup Floriva →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for CHOLECALCIFEROL and SODIUM FLUORIDE →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Prescribing information
From the FDA-approved label for Floriva. Official source: DailyMed (NLM) · Label effective Feb 1, 2024
Indications and usage
Dosage and administration
Warnings
Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
Related drugs
ORLISTAT
Treats same condition · orlistat
Lopid
Treats same condition · gemfibrozil
DESMODA
Treats same condition · Desmopressin Acetate Oral Solution
Tricor
Treats same condition · Fenofibrate
olmesartan medoxomil-hydrochlorothiazide
Treats same condition · olmesartan medoxomil-hydrochlorothiazide
Glumetza
Treats same condition · metformin hydrochloride
Epaned
Treats same condition · enalapril maleate
DAPAGLIFLOZIN
Treats same condition · DAPAGLIFLOZIN
Exforge HCT
Treats same condition · amlodipine valsartan and hydrochlorothiazide
Alogliptin and Pioglitazone
Treats same condition · alogliptin and pioglitazone
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.